Similar articles

• Management of ventricular arrhythmias.

  Fogoros RN. Fogoros RN. Am Fam Physician. 1986 Mar;33(3):236-46. Am Fam Physician. 1986. PMID: 3953344 No abstract available.
• Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation.

  Olsson SB, Edvardsson N. Olsson SB, et al. Am Heart J. 1981 Nov;102(5):864-71. doi: 10.1016/0002-8703(81)90037-5. Am Heart J. 1981. PMID: 7304394 No abstract available.
• [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].

  Scibilia G, Bonatti V, Pavarani A, Tagliavini S, Botti G. Scibilia G, et al. Cardiol Prat. 1973;24(1):79-84. Cardiol Prat. 1973. PMID: 4575451 Clinical Trial. Italian. No abstract available.
• Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.

  Coronel R, Janse MJ, Opthof T, Wilde AA, Taggart P. Coronel R, et al. Heart Rhythm. 2012 Jun;9(6):977-82. doi: 10.1016/j.hrthm.2012.01.021. Epub 2012 Jan 28. Heart Rhythm. 2012. PMID: 22293142 Review.
• Pharmacology of cardiac arrhythmias.

  Singer DH, Ten Eick RE. Singer DH, et al. Prog Cardiovasc Dis. 1969 May;11(6):488-514. doi: 10.1016/0033-0620(69)90003-6. Prog Cardiovasc Dis. 1969. PMID: 4892942 Review. No abstract available.